Browsing by Author Catenacci, Daniel V. T.
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
2015 | Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution | Ling, Shaoping; Hu, Zheng; Yang, Zuyu; Yang, Fang; Li, Yawei; Lin, Pei; Chen, Ke; Dong, Lili; Cao, Lihua; Tao, Yong; Hao, Lingtong; Chen, Qingjian; Gong, Qiang; Wu, Dafei; Li, Wenjie; Zhao, Wenming; Tian, Xiuyun; Hao, Chunyi; Hungate, Eric A.; Catenacci, Daniel V. T.; Hudson, Richard R.; Li, Wen-Hsiung; Lu, Xuemei; Wu, Chung-I |
1-Feb-2020 | Margetuximab (M) combined with anti-PD-1 (MGA012) or anti-PD-1/LAG-3 (MGD013) +/- chemotherapy (CTX) in first-line therapy of advanced/metastatic HER2+gastroesophageal junction (GEJ) or gastric cancer (GC) | Catenacci, Daniel V. T.; Rosales, Minori Koshiji; Wigginton, Jon M.; Chung, Hyun Cheol; Yoon, Harry H.; Shen, Lin; Moehler, Markus H.; Kang, Yoon-Koo |
20-Jan-2021 | Margetuximab (M) combined with anti-PD-1 (retifanlimab) or anti-PD-1/LAG-3 (tebotelimab) plus /- chemotherapy (CTX) in first-line therapy of advanced/metastatic HER2+gastroesophageal junction (GEJ) or gastric cancer (GC). | Catenacci, Daniel V. T.; Rosales, Minori Koshiji; Chung, Hyun Cheol; Yoon, Harry H.; Shen, Lin; Moehler, Markus H.; Kang, Yoon-Koo |